Risk of on-treatment lymphopenia is associated with treatment outcome and efficacy of consolidation immunotherapy in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy-Reference-Cited by-同舟云学术

Risk of on-treatment lymphopenia is associated with treatment outcome and efficacy of consolidation immunotherapy in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy

Published:2023-12 Issue: Volume:189 Page:109934
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Yang Gowoon^ORCID,Yoon Hong In,Lee Joongyo^ORCID,Kim Jihun^ORCID,Kim Hojin,Cho Jaeho^ORCID,Lee Chang Geol,Chang Jee Suk,Cho Yeona,Kim Jin Sung,Kim Kyung Hwan

Funder

National Research Foundation of Korea

Yonsei University College of Medicine

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference21 articles.

1. Survival in patients with severe lymphopenia following treatment with radiation and chemotherapy for newly diagnosed solid tumors;Grossman;J Natl Compr Canc Netw,2015

2. Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes;Tang;Int J Radiat Oncol Biol Phys,2014

3. Higher radiation dose to the immune cells correlates with worse tumor control and overall survival in patients with stage III NSCLC: a secondary analysis of RTOG0617;Jin;Cancers (Basel),2021

4. Impact of radiation dose to the host immune system on tumor control and survival for stage III non-small cell lung cancer treated with definitive radiation therapy;Ladbury;Int J Radiat Oncol Biol Phys,2019

5. Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC;Zhao;Radiat Oncol,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the impact of radiation-induced lymphopenia: Preclinical and clinical research perspectives;Clinical and Translational Radiation Oncology;2024-11

2. Kaplan lecture 2023: lymphopenia in particle therapy;International Journal of Radiation Biology;2024-03-05

3. The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC;Radiotherapy and Oncology;2024-01